Lessons from Real Life Experience: Importance of In-House Sequencing and Smart Ratio-Based Real-Time PCR Outperform Multiplex Ligation-Dependent Probe Amplification in Prenatal Diagnosis for Spinal Muscular Atrophy: Bench to Bedside Diagnosis

• Published in: Global medical genetics 2023-09, Vol.10 (3), p.240-246
• Main Authors: Tuncel, Gulten, Sanlıdag, Burcin, Dirik, Eray, Baris, Tugba, Ergoren, Mahmut Cerkez, Temel, Sehime Gulsun
• Format: Article
• Language: English
• Subjects: in-house testing; MLPA; Original; sequencing; SMA; SMN1
• ISSN: 2699-9404; 2699-9404
• DOI: 10.1055/s-0043-1774307

Spinal muscular atrophy (SMA) is a rare, recessively inherited neurodegenerative disorder caused by the presence of pathogenic variants in the SMN gene. As it is the leading inherited cause of infant mortality, identification of SMN gene pathogenic variant carriers is important for diagnostic purposes with effective genetic counseling. Multiple ligation probe analysis (MLPA), a probe-based method, is considered as the gold standard for SMA carrier analysis. However, MLPA might give false-negative results in cases with variations in the probe-binding regions. Here, we present a case born to consanguineous SMA carrier parents. Prenatal diagnosis with MLPA failed to detect the compound heterozygous mutant state of the proband and she was born unfortunately with SMA phenotype. Further analysis with a real-time polymerase chain reaction kit was able to detect the compound heterozygous state of the patient and was confirmed with targeted next-generation sequencing technology.